Type 1 Papillary Renal Cell Carcinoma Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Papillary Renal Cell Carcinoma Type 1

IndicationStatusPhase
DBCOND0029157 (Type 1 Papillary Renal Cell Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01727089Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney CancerTreatment